Scholars Central

Case reportPublished 18 Jul 2023

Merkel Cell Carcinoma

Authors: Cesar Suarez

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Merkel carcinoma is very rare skin cancer, with high mortality. The standard treatment until 2017 was surgery, radiotherapy, and chemotherapy. Since 2017 FDA and EC approved Avelumab for the marketing and sale, based in phase II clinical trial. In Argentina was approved registration for the treatment of patients with metastatic Merkel cell carcinoma, controversies in authorizations, leads to delay in the start of treatment, and sometimes requires the intervention of the justice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Oncology: Case Reports.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Oncology: Case Reports
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Cesar Suarez”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels